Rheumatoid arthritis

The effect of biological treatment on female fertility: A cohort study of women with rheumatoid arthritis and psoriatic arthritis

Semin Arthritis RheumPublished Retrospective cohort study

Authors' conclusion

This large cohort study provides reassuring data regarding spontaneous and medicated fertility in patients exposed to biological medications.

Study context

Population
Women aged 18–40 years at diagnosis with rheumatoid arthritis (RA) or PsA; biological treatments included TNFi, anti-CD-20 monoclonal antibodies, IL blockers and T-cell inhibitors
Participants
4,517 vs 1,415
Exposure
Women with RA vs patients with PsA exposed to biological drugs
  • RAn = 4,517
  • PsAn = 1,415reference
Outcome
Positive pregnancy test rate
Methodological detailselectronic health record database
  • Electronic health record database

Main finding

As reported in the abstract

Positive pregnancy test (beta hCG) rate
  • Both groups had lower rates of positive beta hCG after diagnosis vs baseline rates before diagnosis
  • Exposure to biological treatment did not negatively affect the likelihood of conception in either group

Observational data: associations, not effects.

Secondary outcomes

Mean age at initiation of biological treatments · not statistically different

P = 0.729

Mean

OutcomeRAPsAP value
Mean age at diagnosisNot statistically different30.7 (SD 6.3)30.9 (SD 6)P = 0.260

Beta hCG testing after initiation of biological treatments

Increased in RA
P < 0.01
Increased in PsA
P = 0.07

Use of fertility medications

Before diagnosis: about 8 % in both groups
P > 0.5
After diagnosis, before exposure: ≈4 % in both groups, then recovered to baseline values
P > 0.5

Post-exposure in vitro fertilization (IVF) rate vs pretreatment

Lower in RA than pretreatment
P < 0.01
Not significantly different in PsA

Original publication

The effect of biological treatment on female fertility: A cohort study of women with rheumatoid arthritis and psoriatic arthritis. Semin Arthritis Rheum. Published 20 December 2024. doi:10.1016/j.semarthrit.2024.152608

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.